Article Versions Notes

Ohno M, Kitanaka C, Miyakita Y, Tanaka S, Sonoda Y, Mishima K, Ishikawa E, Takahashi M, Yanagisawa S, Ohashi K, et al. Metformin with Temozolomide for Newly Diagnosed Glioblastoma: Results of Phase I Study and a Brief Review of Relevant Studies. Cancers. 2022; 14(17):4222. https://doi.org/10.3390/cancers14174222

Ohno, Makoto, Chifumi Kitanaka, Yasuji Miyakita, Shota Tanaka, Yukihiko Sonoda, Kazuhiko Mishima, Eiichi Ishikawa, Masamichi Takahashi, Shunsuke Yanagisawa, Ken Ohashi, and et al. 2022. "Metformin with Temozolomide for Newly Diagnosed Glioblastoma: Results of Phase I Study and a Brief Review of Relevant Studies" Cancers 14, no. 17: 4222. https://doi.org/10.3390/cancers14174222

Ohno, M., Kitanaka, C., Miyakita, Y., Tanaka, S., Sonoda, Y., Mishima, K., Ishikawa, E., Takahashi, M., Yanagisawa, S., Ohashi, K., Nagane, M., & Narita, Y. (2022). Metformin with Temozolomide for Newly Diagnosed Glioblastoma: Results of Phase I Study and a Brief Review of Relevant Studies. Cancers, 14(17), 4222. https://doi.org/10.3390/cancers14174222